Sirdupla

Sirdupla is an inhaled medication combining fluticasone propionate and salmeterol for respiratory conditions. This combination therapy helps manage symptoms like wheezing and shortness of breath. It is designed for daily use to control asthma and COPD symptoms. Not intended for acute attacks.

Sirdupla is used to control and prevent symptoms of asthma and chronic obstructive pulmonary disease (COPD). It combines a corticosteroid (fluticasone propionate) to reduce inflammation and a long-acting bronchodilator (salmeterol) to open airways. This medication is typically prescribed for maintenance therapy rather than quick relief. It helps reduce the frequency of flare-ups and improves breathing over time.

Sirdupla works by reducing swelling in the airways and relaxing muscles to keep them open. Users may notice improved breathing and fewer asthma or COPD symptoms over time. Some people experience a reduction in coughing and wheezing. Regular use is important to maintain these effects.

Store Sirdupla at room temperature away from moisture and heat. Keep the inhaler in a dry place and avoid puncturing the canister. Rinse your mouth after using the inhaler to reduce the risk of oral infections. Always follow the prescribed usage instructions and consult a healthcare provider if symptoms worsen.

Sirdupla may interact with other inhaled medications, especially those containing similar active ingredients. Inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Certain medications, like strong CYP3A4 inhibitors, may increase the risk of side effects. Avoid using Sirdupla with other long-acting bronchodilators unless directed by a doctor.